Barrett Allen
Family · Pueblo, CONPI 1407547193
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AstraZeneca at 30.5% of the total. 2025 is the largest year on record at $1,297, 3.2 times the $407 reported in 2023. Among family clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $26.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$853
- AbbVie$351
- Novo Nordisk$270
- Pfizer$154
- Philips North America LLC$141
- Aimmune Therapeutics, Inc.$116
- plus $912 from 22 others
What the payments were for
- Food & beverage$2,798100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $853 |
| AbbVie | 15 | $351 |
| Novo Nordisk | 9 | $270 |
| Pfizer | 8 | $154 |
| Philips North America LLC | 6 | $141 |
| Aimmune Therapeutics, Inc. | 5 | $116 |
| Lilly USA, LLC | 5 | $102 |
| Bayer | 5 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $89 |
| Amgen | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Alkermes, Inc. | 2 | $53 |
| Novartis | 2 | $48 |
| Nevro Corp. | 2 | $45 |
| GSK | 2 | $41 |
| Tonix Medicines, Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Globus Medical | 1 | $26 |
| Mylan Specialty L.p. | 1 | $26 |
| Cequr Corporation | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Dexcom, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,798 in reported general payments places this provider in the 90th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 30 | $50,787 |
| FarxigaDapagliflozin Propanediol | 24 | $40,900 |
| MounjaroTirzepatide | 24 | $34,135 |
| OzempicSemaglutide | 22 | $26,169 |
| EliquisApixaban | 13 | $17,523 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $11,960 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $8,135 |
| Levemir FlexpenInsulin Detemir | 22 | $5,544 |
| Lidocaine | 33 | $3,704 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $3,405 |
| Diclofenac Sodium | 32 | $2,597 |
| Gabapentin | 106 | $2,024 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 73 | $1,703 |
| Omeprazole | 79 | $1,412 |
| Fluticasone Propionate | 59 | $1,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $102 | $84,92254 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $853 | $60,99569 claims |
| Novo NordiskOzempic | $270 | $26,16922 claims |
| PfizerEliquis | $154 | $17,52313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,182 family providers in Colorado.
Other family in Pueblo
- Lisa CloughPueblo$7K
- Tarah SellnerPueblo$6K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.